期刊文献+

Diagnosis of Hepatocellular Carcinoma by Using Methylation Specific-PCR 被引量:1

Diagnosis of Hepatocellular Carcinoma by Using Methylation Specific-PCR
下载PDF
导出
摘要 To find a more sensitive and earlier diagnostic marker for hepatocellular carcinoma, methylation-profils of CpG islands in the promoter of eleven genes in hepatocellular carcinoma(HCC) carcinoma and pericarcinoma tissues from ten patients were examined by using methylation-specific PCR (MSP) method. MSP was used to detect the methylation of p16, p53, Secreted frizzled-related protein 1 (SFRP 1) and SFRP2 promoters. Meanwhile, plasma alpha-fetoprotein (AFP) levels in 53 patients were also determined. The results showed that HCC was closely correlated to methylation in promoter of tumor-suppressing gene p16, p53, SFRP1 and SFRP2. The results suggest that methylation of SFRP2 promoter is possible a better marker for diagnosis of HCC than plasma Alpha-fetoprotein (AFP) levels. The false negative of SFRP1 and SFRP2 are perfectly complementary. If SFRP1 and SFRP2 were both considered as a complementary positive marker at the same time, the accurate rate for diagnosis of HCC is 100%. To find a more sensitive and earlier diagnostic marker for hepatocellular carcinoma, methylation-profils of CpG islands in the promoter of eleven genes in hepatocellular carcinoma(HCC) carcinoma and pericarcinoma tissues from ten patients were examined by using methylation-specific PCR (MSP) method. MSP was used to detect the methylation of p16, p53, Secreted frizzled-related protein 1 (SFRP 1) and SFRP2 promoters. Meanwhile, plasma alpha-fetoprotein (AFP) levels in 53 patients were also determined. The results showed that HCC was closely correlated to methylation in promoter of tumor-suppressing gene p16, p53, SFRP1 and SFRP2. The results suggest that methylation of SFRP2 promoter is possible a better marker for diagnosis of HCC than plasma Alpha-fetoprotein (AFP) levels. The false negative of SFRP1 and SFRP2 are perfectly complementary. If SFRP1 and SFRP2 were both considered as a complementary positive marker at the same time, the accurate rate for diagnosis of HCC is 100%.
出处 《Wuhan University Journal of Natural Sciences》 CAS 2007年第3期558-562,共5页 武汉大学学报(自然科学英文版)
基金 Suported by the Scientific and Technology Bureau of Hubei Province Foundation (2005AA301C26)
关键词 METHYLATION tumor-suppressing gene hepatocellular carcinoma (HCC) methylation tumor-suppressing gene hepatocellular carcinoma (HCC)
  • 相关文献

参考文献10

  • 1Bosch F X,Ribes J,Cleries R,et al.Epidemiology of Hepa-tocellular Carcinoma[].Clinics in Liver Disease.2005
  • 2Johnson R C.Hepatocellular Carcinoma[].Hepatogastroen-terology.1997
  • 3Herman J G,Baylin S B.Gene Silencing in Cancer in Asso-ciation with Promoter Hypermethylation[].The New England Journal of Medicine.2003
  • 4Huang Q X,Jin F,Huang H F.Methodology of DNA Methy-lation[].Section Genet Foreign Med Sci.2004
  • 5Patthy L.The WIF Module[].Trends in Biochemical Sciences.2000
  • 6Mao B,Wu W,Li Y,et al.LDL-Receptor-Related Protein 6 is a Receptor for Dickkopf Proteins[].Nature.2001
  • 7Caldwell G M,Jones C,Gensberg K,et al.The Wnt Antago-nist sFRP1 in Colorectal Tumorigenesis[].Cancer Research.2004
  • 8Usadel H,Brabender J,Danenberg K D,et al.Quantitative Adenomatous Polyposis Coli Promoter Methylation Analysis in Tumor Tissue, Serum, and Plasma DNA of Patients with Lung Cancer[].Cancer Research.2002
  • 9JIANYU,HONGYuZHANG,ZHENZHONGMA,WEILU,YIFEIWANG,JINGDEZHU.Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis[J].Cell Research,2003,13(5):319-333. 被引量:34
  • 10Melkonyan H S,Chang W C,Shapiro J P,et al.SARPs: a Family of Secreted Apoptosis-Related Proteins[].Proceedings of the National Academy of Sciences of the United States of America.1997

二级参考文献66

  • 1Venkataraman G M, gi Yatin, R Marcinek and K B Ain. Restoration of iodide uptake in dedifferentiated thyroid carcinoma:relationship to human Na+/I-symporter gene methylation status. J Clin Endocrinol Metab 1999; 84(7):2449-57.
  • 2Cui J, L R Rohr, G Swanson, V O Speights, T Maxwell and A R Brothman. Hypermethylation of the caveolin- 1 gene promoter in prostate cancer. Prostate 2001: 46(3):249-56.
  • 3Toyota M, C Ho, N Ahuja, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999; 59(10):2307-12.
  • 4Ferlay J, F Bray, P Pisani and D M Parkin. GOBOCAB 2000 Cancer Incidence, Mortality and Prevalence Worldwide,. Lyon:IARC Scienctific Publications, IARC Press, 2001.
  • 5Parkin D, P Pisani and J Ferlay. Global cancer statistics. CA Cancer J. Clin., 1999; 49:33-64.
  • 6Cancer Incidence and Mortality in China, 1993-1997 (Selected Cities and Counties). Beijing: China Publishing House of Medical Sciences and Technologies, 1998.
  • 7Feitelson M A, B Sun, N L Satiroglu Tufan, J Liu, J Pan and Z Lian. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21(16):2593-604.
  • 8Kim J W and X W Wang. Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?Carcinogenesis 2003; 24(3):363-9.
  • 9Wang X W, S P Hussain, T I Huo, et al. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 2002; 181-182:43 -7.
  • 10Baylin S and T H Bestor. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 2002;1(4):299-305.

共引文献33

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部